Search peptides, terms, sources/
Research source · 2015

Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria

About this source

Kind
Research
Design
Human observational
Population
115 patients with erythropoietic protoporphyria who received 1,023 implants over up to 8 years
Sample size
115
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Observational, no control group. Quality-of-life scores are self-reported. About 23% stopped treatment.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.